DBCO-PEG-OH (MW 600)
DBCO-PEG-OH (MW 600) is a PEG derivative composed of DBCO, PEG, and hydroxyl groups. DBCO-PEG-OH (MW 600) contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups[1].
Product Specifications
UNSPSC
12352200
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Smiles
O=C(CCCCC(NCCO[H])=O)N(C1)C2=C(C=CC=C2)C#CC3=C1C=CC=C3.[n]
Molecular Weight
600 (Average)
References & Citations
[1]Koo J, et al. Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles. J Control Release. 2025 Feb 10;378:997-1012.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040977-100 1x 100 µL
TGF-beta (1D11.16.8), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400031-100 1x 100 µL
Mucin 5AC (MUC5AC) (45M1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 